Skip to content
ppharmaranks
Menu
Class IIOngoing

traMADol Hydrochloride Tablets recall

FDA recall D-0487-2024 · initiated Apr 26, 2024

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated May 15, 2024How we research

Rubicon Research Private Limited recalled traMADol Hydrochloride Tablets in Apr 2024 — an FDA Class II recall (D-0487-2024) because Presence of Foreign Tablets: Pharmacist reported a tablet of baclofen in a bottle of 1000-count tramadol.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Presence of Foreign Tablets: Pharmacist reported a tablet of baclofen in a bottle of 1000-count tramadol

Something got into the product

A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot #: 230774Hl, Exp 4/30/2026

Quantity recalled: 2,592 1000-count Bottles

Details

Product
traMADol Hydrochloride Tablets, USP 50 mg, 1000-count bottle, Rx Only, Distributed by: Advagen Pharma Limited, 666 Plainsboro Road Suite 605, Plainsboro, NJ, 08536, USA, Manufactured by: Rubicon Research, Private Limited, Ambernath, Dist. Thane, 421506 India NDC 72888-080-00
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide in the USA
Initiated
Apr 26, 2024
FDA report date
May 15, 2024
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was traMADol Hydrochloride Tablets recalled?
Rubicon Research Private Limited recalled traMADol Hydrochloride Tablets in Apr 2024 — an FDA Class II recall (D-0487-2024) because Presence of Foreign Tablets: Pharmacist reported a tablet of baclofen in a bottle of 1000-count tramadol. May cause temporary or medically reversible harm; low probability of serious harm.
Why was traMADol Hydrochloride Tablets recalled?
Per the FDA enforcement record, the reason for recall D-0487-2024 was: Presence of Foreign Tablets: Pharmacist reported a tablet of baclofen in a bottle of 1000-count tramadol
Is a recalled traMADol Hydrochloride Tablets dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of traMADol Hydrochloride Tablets are affected?
Distributed: Nationwide in the USA. The recall covers these lots — Lot #: 230774Hl, Exp 4/30/2026. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0487-2024.

Source: openFDA Drug Enforcement record D-0487-2024

← All drug recalls